Acumen
TTP LabTech’s innovative Acumen eX3 has become established as a market leader for high throughput analysis of high content assays. Now in its third generation, it has become firmly established as an industry standard for organisations seeking to increase the throughput and multiplexing of fluorescent cell-based assays and has facilitated the movement of these assays into the domain of primary screening.
Acumen eX3’s laser-scanning approach enables the scanning of entire wells, cell by cell, ideal for analysis of large objects and improved assay robustness. Customer-driven software applies cytometric principles rather than image analysis making for less labour-intensive screening with a broad range of high content assays.
Acumen eX3 represents a breakthrough technology by offering a range of benefits including:
- high throughput for sustained primary screening
- rapid data collection
- easy integration into existing workflows
- enhanced multiplexing capability to maximise data content
- proven capability for a broad range of assays including:
- compound, or pathway profiling capabilities
- rapid genome-wide analysis
- increased data confidence of whole well scanning
- 24/7 operation from an automation-friendly design
Acumen eX3 has been implemented at many stages of the drug discovery process and by virtue of its flexibility has been applied to the quantitative analysis of a broad range of biological applications including; toxicity testing, viral infectivity, cell cycle, cell proliferation, protein kinase activity and reporter gene assays.
The dynamic functionality of Acumen eX3 can allow it to become an enabling platform for your organisation.
Acumen Overview Video
For further information on any of our products or services or to request a product demonstration please contact us at sales@ttplabtech.com

